By David Tuller, DrPH The National Institute for Health and Care Excellence, the U.K. organization that develops clinical guidelines for medical conditions, has rejected my freedom-of-information request for the names of the experts involved in the reassessment of the guidance for the illness it calls CFS/ME. This isn't surprising, since ...

By David Tuller, DrPH The Countess of Mar, a well-known advocate for ME/CFS patients in the House of Lords, has received a negative response to her request for the names of the experts involved in the review of the NICE guideline for CFS/ME. The ME Association has not yet received ...

By David Tuller, DrPH This month, the U.K. organization currently assessing whether to update the clinical guidelines for the illness it calls CFS/ME is seeking input from stakeholders in the process. Unfortunately, that's not good news, it's bad news. Why? The National Institute for Health and Care Excellence, or NICE, ...

By David Tuller, DrPH This is the beginning of a new phase for Trial by Error. I initially assumed that my work on PACE and ME/CFS (or ME, or CFS/ME, or CFS) would be a one-off investigation, and then I'd move on to other projects. But after my 15,000-word series ...

by Steven Lubet On 1 June 2017, Professor Michael Sharpe presented the Special Ethics Seminar at Oxford University's St Cross College. In his posted abstract, he asserted that some areas of scholarship are politicised (U.K. spelling in original), including the role of psychiatric or psychological approaches in the treatment of ...